pROC-Chemotype Plots Enhance the Interpretability of Benchmarking Results in Structure-Based Virtual Screening

被引:19
|
作者
Ibrahim, Tamer M. [1 ]
Bauer, Matthias R. [1 ]
Doerr, Alexander [2 ]
Veyisoglu, Erdem [1 ]
Boeckler, Frank M. [1 ,2 ]
机构
[1] Univ Tubingen, Lab Mol Design & Pharmaceut Biophys, Dept Pharmaceut & Med Chem, Inst Pharmaceut Sci, D-72076 Tubingen, Germany
[2] Univ Tubingen, Ctr Bioinformat Tubingen ZBIT, D-72076 Tubingen, Germany
关键词
PROTEIN-LIGAND DOCKING; MOLECULAR DOCKING; SCORING FUNCTIONS; GENETIC ALGORITHM; DIHYDROFOLATE-REDUCTASE; ACCURATE DOCKING; VALIDATION; ENRICHMENT; SETS; SELECTION;
D O I
10.1021/acs.jcim.5b00475
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recently, we have reported a systematic comparison of molecular preparation protocols (using MOE or Maestro) in combination with two docking tools (GOLD or Glide), employing our DEKOIS 2.0 benchmark sets. Herein, we demonstrate how comparable settings of data preparation protocols can affect the profile and AUG of pROC curves based on variations in chemotype enrichment. We show how the recognition of different classes of chemotypes can affect the docking performance, particularly in the early enrichment, and monitor changes in this recognition behavior based on score normalization and rescoring strategies. For this, we have developed "pROC-Chemotype", which is an automated protocol that matches and visualizes ligand chemotype information together with potency classes in the pROC profiles obtained by docking. This tool enhances the understanding of the influence of chemotype recognition in early enrichment, but also reveals trends of impaired recognition of chemotype classes at the end of the score-ordered rank. Identifying such issues helps to devise score-normalization strategies to overcome this potential bias in an intuitive manner. Furthermore, strong perturbations in chemotype ranking between different methods can help to identify the underlying reasons (e.g., changes in the protonation/tautomerization state). It also assists in the selection of appropriate scoring functions that are capable to retrieve more potent and diverse hits. In summary, we demonstrate how this new tool can be utilized to identify and highlight chemotype-specific behavior, e.g., in dataset preparation. This can help to overcome some chemistry-related bias in virtual screening campaigns. pROC-Chemotype is made freely available at www.dekois.com.
引用
收藏
页码:2297 / 2307
页数:11
相关论文
共 50 条
  • [1] Molecular dynamics to enhance structure-based virtual screening on cathepsin B
    Ogrizek, Mitja
    Turk, Samo
    Lesnik, Samo
    Sosic, Izidor
    Hodoscek, Milan
    Mirkovic, Bojana
    Kos, Janko
    Janezic, Dusanka
    Gobec, Stanislav
    Konc, Janez
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2015, 29 (08) : 707 - 712
  • [2] Molecular dynamics to enhance structure-based virtual screening on cathepsin B
    Mitja Ogrizek
    Samo Turk
    Samo Lešnik
    Izidor Sosič
    Milan Hodošček
    Bojana Mirković
    Janko Kos
    Dušanka Janežič
    Stanislav Gobec
    Janez Konc
    Journal of Computer-Aided Molecular Design, 2015, 29 : 707 - 712
  • [3] Structure-Based Pharmacophores for Virtual Screening
    Loewer, Martin
    Proschak, Ewgenij
    MOLECULAR INFORMATICS, 2011, 30 (05) : 398 - 404
  • [4] Structure-based virtual screening: an overview
    Lyne, PD
    DRUG DISCOVERY TODAY, 2002, 7 (20) : 1047 - 1055
  • [5] Structure-based virtual ligand screening
    Villoutreix, Bruno O.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2006, 7 (05) : 367 - 367
  • [6] Emerging Topics in Structure-Based Virtual Screening
    Giulio Rastelli
    Pharmaceutical Research, 2013, 30 : 1458 - 1463
  • [7] Virtual screening in structure-based drug discovery
    Barril, X
    Hubbard, RE
    Morley, SD
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (07) : 779 - 791
  • [8] The Science and Art of Structure-Based Virtual Screening
    Zhao, Hongtao
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (04): : 436 - 440
  • [9] Emerging Topics in Structure-Based Virtual Screening
    Rastelli, Giulio
    PHARMACEUTICAL RESEARCH, 2013, 30 (05) : 1458 - 1463
  • [10] Challenges and advances in structure-based virtual screening
    Yuriev, Elizabeth
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (01) : 5 - 7